Five genetic variants and six mutational patterns of SARS-CoV-2, the pathogen that causes Covid-19, are currently circulating in Cuba, health authorities informed.
Science and Health
The integrated marketing of the Villa Clara destination, together with the quality, environmental and sustainable development efforts, are among the main scientific and innovation projects conducted by the local scholars aimed at a greater growth in the national tourism.
How to contribute more by means of the innovation to the food production and the quality of life of the population of Villa Clara in these times of COVID-19, was the call of the participants at the balance meeting of the Productive Scientific Pole that was held at the Provincial Government headquarters.
The first week of phase III clinical trials of Cuban anti-COVID vaccine Soberana 02, with volunteers between 19 and 80 years of age, was completed in strict compliance with internationally established protocols.
The Institute of Neurology and Neurosurgery "Dr. Rafael Estrada Gonzalez" (INN) plans to start soon a study of neurological manifestations associated with the COVID-19 pandemic in recovered patients from Plaza de la Revolucion municipality in Havana.
Cuban President Miguel Diaz-Canel said that in the face of unfavorable predictions about the ongoing COVID-19 spread in the country, authorities and scientists have joint efforts to lower the prevalence of the virus on the island nation.
With more than 500 highly effective kidney transplants, the Arnaldo Milian Castro University Clinical-Surgical Hospital of Villa Clara is close to the 20th anniversary of the restart of this type of medical service, on July 15th, 2001.
The National Center for the Production of Laboratory Animals ( CENPALAB by its Spanish acronym) is essential for the development of Cuba's biotechnological industry and has been crucial for the preclinical testing of the island's vaccine candidates against COVID-19.
Cuba will have the required doses of its most effective Covid-19 vaccine to immunize its entire population in August, the president of BioCubaFarma, Eduardo Martinez, confirmed on Wednesday.
The Cuban people will be immunized against COVID-19 in 2021 following the proven efficacy of its vaccine candidates Soberana 02, currently on phase 3 trials and Abdala about to enter that phase.
The winners of the Alfredo Nieto Dopico Scientific Journalism Contest of Villa Clara received their awards as part of the celebrations for the Day of the Cuban Press, which is celebrated on March 14th.
The scientific community of Villa Clara received once again happy news, as the experts at the Center for Center for Chemical Bioactive Products at the UCLV (CBQ) have just obtained the National Award for Technological Innovation, awarded by the Ministry of Science, Technology and the Environment (CITMA).
Every February 18th comes to remember that there are people in the world who interact and think in a different way, but in this lies the peculiarity, the singularity, of such beauty and diversity that we can enjoy.